Literature DB >> 33130455

Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β-negative cognitively normal individuals.

Colin Groot1, Vincent Doré2, Joanne Robertson3, Samantha C Burnham4, Greg Savage5, Rik Ossenkoppele6, Christopher C Rowe7, Victor L Villemagne7.   

Abstract

We examined whether mesial temporal (Me) tau relates to cognitive performance in 47 amyloid-β (Aβ)-negative, cognitively normal older adults (>60 years old). Me-tau was measured using [18F]flortaucipir-positron emission tomography standardized uptake value ratio. The effect of continuous and categorical (stratified at standardized uptake value ratio = 1.2 [21% Me-positive]) Me-tau on cognition (mini-mental state examination, pre-Alzheimer's cognitive composite, a memory composite, and a nonmemory composite score) was examined using general linear models, and associations between Me-tau and [18F]flortaucipir signal in the neocortex were assessed using voxelwise regressions (continuous) and voxelwise contrasts (categorical). In addition, we assessed the effect of age and Aβ burden on Me-tau. Both continuous and categorical Me-tau was associated with worse cognitive performance across all tests and with higher lateral temporal and parietal [18F]flortaucipir signal. Furthermore, we observed a marginal association between Me-tau and age, whereas there was no association with Aβ burden. Our findings indicate that Me-tau in Aβ-negative cognitively normal individuals, which is likely age-related (i.e., primary age-related tauopathy), might not be as benign as commonly thought.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mesial temporal lobe; PART; PET; Tau

Year:  2020        PMID: 33130455     DOI: 10.1016/j.neurobiolaging.2020.09.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

Review 1.  Recent update on the heterogeneity of the Alzheimer's disease spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-12-17       Impact factor: 3.575

2.  Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.

Authors:  Xi Chen; Kaitlin E Cassady; Jenna N Adams; Theresa M Harrison; Suzanne L Baker; William J Jagust
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

3.  Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults.

Authors:  Tengfei Guo; Susan M Landau; William J Jagust
Journal:  Alzheimers Res Ther       Date:  2021-10-15       Impact factor: 6.982

4.  Sex and APOE ɛ4 modify the effect of cardiovascular risk on tau in cognitively normal older adults.

Authors:  Amaryllis A Tsiknia; Emilie Reas; Katherine J Bangen; Erin E Sundermann; Linda McEvoy; James B Brewer; Steven D Edland; Sarah J Banks
Journal:  Brain Commun       Date:  2022-02-18

Review 5.  What's the cut-point?: a systematic investigation of tau PET thresholding methods.

Authors:  Alexandra J Weigand; Anne Maass; Graham L Eglit; Mark W Bondi
Journal:  Alzheimers Res Ther       Date:  2022-04-05       Impact factor: 8.823

6.  Mesial temporal tau in amyloid-β-negative cognitively normal older persons.

Authors:  Natasha Krishnadas; Vincent Doré; Colin Groot; Fiona Lamb; Pierrick Bourgeat; Samantha C Burnham; Kun Huang; Anita M Y Goh; Colin L Masters; Victor L Villemagne; Christopher C Rowe
Journal:  Alzheimers Res Ther       Date:  2022-04-08       Impact factor: 8.823

7.  Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases.

Authors:  Natasha Krishnadas; Vincent Doré; Simon M Laws; Tenielle Porter; Fiona Lamb; Svetlana Bozinovski; Victor L Villemagne; Christopher C Rowe
Journal:  Alzheimers Dement (Amst)       Date:  2022-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.